Takeuchi Hidemi, Uchida Haruhito A, Kakio Yuki, Okuyama Yuka, Okuyama Michihiro, Umebayashi Ryoko, Wada Kentaro, Sugiyama Hitoshi, Sugimoto Ken, Rakugi Hiromi, Wada Jun
1Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
7Department of Internal Medicine, Innoshima General Hospital, Hiroshima, Japan.
Aging Dis. 2018 Apr 1;9(2):192-207. doi: 10.14336/AD.2017.0429. eCollection 2018 Apr.
The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The aim of this study was to identify the prevalence and predictors of frailty in Japanese HD patients. This study was a multicenter, cross-sectional and observational investigation conducted at 6 institutions. To evaluate frailty, the modified Fried's frailty phenotype adjusted for Japanese as the self-reported questionnaire was used. Of the 542 patients visiting each institution, 388 were enrolled in this study. In total, 26.0% of participants were categorized as not-frailty, 52.6% as pre-frailty and 21.4% as frailty. The prevalence of frailty increased steadily with age and was more prevalent in females than in males and the subjects with frailty received polypharmacy. A multivariate logistic regression analysis revealed that the factors independently associated with frailty were the following: female gender (odds ratio [OR] = 3.661, 95% confidence interval [CI] 1.398-9.588), age (OR = 1.065, 95% CI 1.014-1.119), age ≥ 75 years old (OR = 4.892, 95% CI 1.715-13.955), body mass index (BMI) < 18.5 (OR = 0.110, 95% CI 0.0293-0.416), number of medications being taken (OR = 1.351, 95% CI 1.163-1.570), diabetes mellitus (DM) (OR = 2.765, 95% CI 1.081-7.071) and MNA-SF ≤ 11 (OR = 7.405, 95% CI 2.732-20.072). Frailty was associated with the accumulation of risk factors. The prevalence of frailty in Japanese patients with HD was relatively lower than that previously reported in Western developed countries; however, it was extremely high compared to the general population regardless of age. Our findings suggest that frailty might be associated with an increase in the prevalence of adverse health outcomes in patients with HD.
全球范围内,接受透析治疗的人群正在老龄化,在日本尤为明显。衰弱是老年人群中最突出的临床状况。慢性肾脏病患者存在衰弱的潜在病理生理因素,而终末期肾病患者的这些因素更为突出。本研究旨在确定日本血液透析患者中衰弱的患病率及预测因素。本研究是在6家机构开展的一项多中心、横断面观察性调查。为评估衰弱情况,使用了针对日本人调整后的改良弗里德衰弱表型作为自填式问卷。在每家机构就诊的542例患者中,388例纳入本研究。总体而言,26.0%的参与者被归类为非衰弱,52.6%为衰弱前期,21.4%为衰弱。衰弱的患病率随年龄稳步上升,女性比男性更常见,且衰弱患者使用多种药物。多因素logistic回归分析显示,与衰弱独立相关的因素如下:女性(比值比[OR]=3.661,95%置信区间[CI]1.398 - 9.588)、年龄(OR = 1.065,95% CI 1.014 - 1.119)、年龄≥75岁(OR = 4.892,95% CI 1.715 - 13.955)、体重指数(BMI)<18.5(OR = 0.110,95% CI 0.0293 - 0.416)、正在服用的药物数量(OR = 1.351,95% CI 1.163 - 1.570)、糖尿病(DM)(OR = 2.765,95% CI 1.081 - 7.071)和微型营养评定简表(MNA - SF)≤11(OR = 7.405,95% CI 2.732 - 20.072)。衰弱与危险因素的累积有关。日本血液透析患者中衰弱的患病率相对低于西方发达国家先前报道的水平;然而,与各年龄段的普通人群相比仍极高。我们的研究结果表明,衰弱可能与血液透析患者不良健康结局患病率的增加有关。